Deluca HF, Cantorna MT.Vitamin D:its role and uses in immunology[J].FASEB J,2001, 15(14):2579-2585.
[2]
Watabe H, Soma Y, Kawa Y, et al.Differentiation of murine melanocyte precursors induced by 1,25-dihydroxyvitamin D3 isassociated with the stimulation of endothelin B receptor expression[J].J Invest Dermatol,2002, 119(3):583-589.
Sun J.Vitamin D and mucosal immune function[J].Curr Opin Gastroenterol,2010,26(6):591-595.
[7]
Gao L, Tao Y, Zhang L, et al.Vitam in D receptor genetic polymorphisms and tuberculosis:updated system atic review and meta-analysis[J].Int J Tuberc Lung Dis, 2010, 14:15-23.
[8]
Wu Wong JR.Potentia l for vitam in Dreceptor agonists in the treatment of cardiovascular disease[J].Br J Pharmacol, 2009, 158:395-412.
[9]
Peterlik M, Grant WB, Cross HS.Calcium, vitamin D and cancer[J].Anticancer Res, 2009, 29:3687-3698.
[10]
Kostner K, Denzer N, Muller CS, et al.The relevance of vitamin D receptor(VDR)genepolymorphisms for cancer:a review of the literature[J].Anticancer Res, 2009, 29:3511-3536.
[11]
Hann SK, Park YK, Lee KG, et al.Epidermal changes in active vitiligo[J].J Dermatol,1992,19(4):217-222.
[12]
Cantorna MT, Zhu Y, Froicu M, et al.Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system[J].Am J Clin Nutr,2004,80(6 Suppl):1717-1720.
[13]
Birlea SA, BirleaM, Cimponeriu D, et al.Auto immune diseases and vitamin D receptor Apa-I polymorphism are associat with vitiligo in a small inbred Romanian community [J].Acta Derm Venereol,2006,86(3):209-214.
Ayding？z IE, Bingül I, Do？ˇru-Abbaso？ˇlu S, et al.Analysis of vitaminD receptor gene polymorphisms in vitiligo[J].Dermatol,2012,224(4):361-368.
[18]
Li K, Shi Q, Yang L, et al. The association of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels with generalized vitiligo[J].Br J Dermatol,2012,167(4):815-821.
[19]
Spritz RA.Recent progress in the genetics of generalized vitiligo[J].J Genet Genomics,2011,38(7):271-278.
